High versus low-dose rate brachytherapy for cervical cancer

Area of Science:

• Oncology
• Radiotherapy
• Gynecologic Oncology

Background:

• Brachytherapy is crucial for cervical cancer treatment.
• Limited US data exists comparing high-dose rate (HDR) and low-dose rate (LDR) brachytherapy outcomes.
• This study examines HDR brachytherapy utilization and its survival impact in the US.

Purpose of the Study:

• To analyze the utilization trends of HDR brachytherapy for cervical cancer in the US.
• To compare survival outcomes between HDR and LDR brachytherapy for cervical cancer patients.

Main Methods:

• Analysis of 10,564 women with stages IB2-IVA cervical cancer from the National Cancer Database (NCDB) (2003-2011).
• Utilized generalized linear mixed models and Cox proportional hazards regression.
• Examined predictors of HDR use and its association with survival.

Main Results:

• HDR brachytherapy use increased from 50.2% to 83.9% between 2003-2011.
• Year of diagnosis was the strongest predictor for HDR use; no significant clinical or socioeconomic factors were associated.
• Multivariable Cox models and Kaplan-Meier analyses showed similar survival rates between HDR and LDR brachytherapy groups across different stages and histologies.

Conclusions:

• The adoption of HDR brachytherapy for cervical cancer has rapidly increased.
• Overall survival rates are comparable between HDR and LDR brachytherapy for cervical cancer.